NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1958684025|ref|XP_038950484|]
View 

protein O-mannose kinase isoform X1 [Rattus norvegicus]

Protein Classification

protein kinase family protein( domain architecture ID 229378)

protein kinase family protein may catalyze the transfer of the gamma-phosphoryl group from ATP to substrates such as serine/threonine and/or tyrosine residues on proteins, or may be a pseudokinase

CATH:  1.10.510.10
PubMed:  16244704
SCOP:  4003661

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PKc_like super family cl21453
Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the ...
104-194 4.73e-09

Protein Kinases, catalytic domain; The protein kinase superfamily is mainly composed of the catalytic domains of serine/threonine-specific and tyrosine-specific protein kinases. It also includes RIO kinases, which are atypical serine protein kinases, aminoglycoside phosphotransferases, and choline kinases. These proteins catalyze the transfer of the gamma-phosphoryl group from ATP to hydroxyl groups in specific substrates such as serine, threonine, or tyrosine residues of proteins.


The actual alignment was detected with superfamily member cd14066:

Pssm-ID: 473864 [Multi-domain]  Cd Length: 272  Bit Score: 56.51  E-value: 4.73e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 104 VALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYHPLGSLsnlEETLNLSKYRDVNTWQHRL 178
Cdd:cd14066    20 VAVKRLnemNCAASKKEFLTELEMLGRLRHPNLVRLLGYCLESDekLLVYEYMPNGSL---EDRLHCHKGSPPLPWPQRL 96
                          90
                  ....*....|....*.
gi 1958684025 179 RLAVEYVSIINYLHHS 194
Cdd:cd14066    97 KIAKGIARGLEYLHEE 112
 
Name Accession Description Interval E-value
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
104-194 4.73e-09

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 56.51  E-value: 4.73e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 104 VALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYHPLGSLsnlEETLNLSKYRDVNTWQHRL 178
Cdd:cd14066    20 VAVKRLnemNCAASKKEFLTELEMLGRLRHPNLVRLLGYCLESDekLLVYEYMPNGSL---EDRLHCHKGSPPLPWPQRL 96
                          90
                  ....*....|....*.
gi 1958684025 179 RLAVEYVSIINYLHHS 194
Cdd:cd14066    97 KIAKGIARGLEYLHEE 112
PK_Tyr_Ser-Thr pfam07714
Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role ...
80-192 6.97e-08

Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyze the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyze the reverse process. Protein kinases fall into three broad classes, characterized with respect to substrate specificity; Serine/threonine-protein kinases, tyrosine-protein kinases, and dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins). This entry represents the catalytic domain found in a number of serine/threonine- and tyrosine-protein kinases. It does not include the catalytic domain of dual specificity kinases.


Pssm-ID: 462242 [Multi-domain]  Cd Length: 258  Bit Score: 52.88  E-value: 6.97e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  80 VRQLKLVGEGAVKRVFLSEWNEH------KVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILT 148
Cdd:pfam07714   1 LTLGEKLGEGAFGEVYKGTLKGEgentkiKVAVKTLkegADEEEREDFLEEASIMKKLDHPNIVKLLGVCTQGEPlyIVT 80
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|
gi 1958684025 149 EYHPLGSLSNLeetlnLSKYRDVNTWQHRLRLAV------EYVSIINYLH 192
Cdd:pfam07714  81 EYMPGGDLLDF-----LRKHKRKLTLKDLLSMALqiakgmEYLESKNFVH 125
TyrKc smart00219
Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.
83-192 1.84e-07

Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.


Pssm-ID: 197581 [Multi-domain]  Cd Length: 257  Bit Score: 51.76  E-value: 1.84e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025   83 LKLVGEGAVKRVFLSEWNEH------KVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYH 151
Cdd:smart00219   4 GKKLGEGAFGEVYKGKLKGKggkkkvEVAVKTLkedASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEplYIVMEYM 83
                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....*..
gi 1958684025  152 PLGSLSNLeetlnLSKYRDVNTWQHRLRLAV------EYVSIINYLH 192
Cdd:smart00219  84 EGGDLLSY-----LRKNRPKLSLSDLLSFALqiargmEYLESKNFIH 125
 
Name Accession Description Interval E-value
STKc_IRAK cd14066
Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases ...
104-194 4.73e-09

Catalytic domain of the Serine/Threonine kinases, Interleukin-1 Receptor Associated Kinases and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. Some IRAKs may also play roles in T- and B-cell signaling, and adaptive immunity. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK-1, -2, and -4 are ubiquitously expressed and are active kinases, while IRAK-M is only induced in monocytes and macrophages and is an inactive kinase. Variations in IRAK genes are linked to diverse diseases including infection, sepsis, cancer, and autoimmune diseases. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain (a pseudokinase domain in the case of IRAK3), and a C-terminal domain; IRAK-4 lacks the C-terminal domain. This subfamily includes plant receptor-like kinases (RLKs) including Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1). BAK1 functions in BR (brassinosteroid)-regulated plant development and in pathways involved in plant resistance to pathogen infection and herbivore attack. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The IRAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270968 [Multi-domain]  Cd Length: 272  Bit Score: 56.51  E-value: 4.73e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 104 VALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYHPLGSLsnlEETLNLSKYRDVNTWQHRL 178
Cdd:cd14066    20 VAVKRLnemNCAASKKEFLTELEMLGRLRHPNLVRLLGYCLESDekLLVYEYMPNGSL---EDRLHCHKGSPPLPWPQRL 96
                          90
                  ....*....|....*.
gi 1958684025 179 RLAVEYVSIINYLHHS 194
Cdd:cd14066    97 KIAKGIARGLEYLHEE 112
PKc cd00180
Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group ...
87-327 1.64e-08

Catalytic domain of Protein Kinases; PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. PKs make up a large family of serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and more than 500 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase.


Pssm-ID: 270622 [Multi-domain]  Cd Length: 215  Bit Score: 54.20  E-value: 1.64e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  87 GEGAVKRVFLSEW--NEHKVAL---SRLTRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLGSLSNL 159
Cdd:cd00180     2 GKGSFGKVYKARDkeTGKKVAVkviPKEKLKKLLEELLREIEILKKLNHPNIVKLYDVFETENFlyLVMEYCEGGSLKDL 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 160 eetlnLSKYRDVNTWQHRLRLAVEYVSIINYLHHSPLGTRvmcdsnDL-PKTLsqyLLTSNFSIVANDLD-ALPLVDHGS 237
Cdd:cd00180    82 -----LKENKGPLSEEEALSILRQLLSALEYLHSNGIIHR------DLkPENI---LLDSDGTVKLADFGlAKDLDSDDS 147
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 238 RVLVKCGHRELHgdFVAPEQLWPygedtpfqddlmPPYDEKIDIWkipdvSsflLGhvegsdMVRFHLFDIH---KACKN 314
Cdd:cd00180   148 LLKTTGGTTPPY--YAPPELLGG------------RYYGPKVDIW-----S---LG------VILYELEELKdliRRMLQ 199
                         250
                  ....*....|...
gi 1958684025 315 QFPAERPTAQNVL 327
Cdd:cd00180   200 YDPKKRPSAKELL 212
STKc_MAP3K-like cd13999
Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine ...
86-322 3.15e-08

Catalytic domain of Mitogen-Activated Protein Kinase (MAPK) Kinase Kinase-like Serine/Threonine kinases; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed mainly of MAP3Ks and similar proteins, including TGF-beta Activated Kinase-1 (TAK1, also called MAP3K7), MAP3K12, MAP3K13, Mixed lineage kinase (MLK), MLK-Like mitogen-activated protein Triple Kinase (MLTK), and Raf (Rapidly Accelerated Fibrosarcoma) kinases. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Also included in this subfamily is the pseudokinase Kinase Suppressor of Ras (KSR), which is a scaffold protein that functions downstream of Ras and upstream of Raf in the Extracellular signal-Regulated Kinase (ERK) pathway.


Pssm-ID: 270901 [Multi-domain]  Cd Length: 245  Bit Score: 53.70  E-value: 3.15e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  86 VGEGAVKRVFLSEWNEHKVALSRLTRLEM----KEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLGSLSNL 159
Cdd:cd13999     1 IGSGSFGEVYKGKWRGTDVAIKKLKVEDDndelLKEFRREVSILSKLRHPNIVQFIGACLSPPPlcIVTEYMPGGSLYDL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 160 eetlnLSKYRDVNTWQHRLRLAVEYVSIINYLHHSPLGTRvmcdsnDLpKTLSqYLLTSNFSIVandldalpLVDHG-SR 238
Cdd:cd13999    81 -----LHKKKIPLSWSLRLKIALDIARGMNYLHSPPIIHR------DL-KSLN-ILLDENFTVK--------IADFGlSR 139
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 239 VLVKCGhrELHGDFV------APEQLwpygedtpfqddLMPPYDEKIDIW------------KIP--DVSSFLLGHVEGS 298
Cdd:cd13999   140 IKNSTT--EKMTGVVgtprwmAPEVL------------RGEPYTEKADVYsfgivlwelltgEVPfkELSPIQIAAAVVQ 205
                         250       260       270
                  ....*....|....*....|....*....|..
gi 1958684025 299 DMVR--------FHLFDIHKACKNQFPAERPT 322
Cdd:cd13999   206 KGLRppippdcpPELSKLIKRCWNEDPEKRPS 237
PK_Tyr_Ser-Thr pfam07714
Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role ...
80-192 6.97e-08

Protein tyrosine and serine/threonine kinase; Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyze the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyze the reverse process. Protein kinases fall into three broad classes, characterized with respect to substrate specificity; Serine/threonine-protein kinases, tyrosine-protein kinases, and dual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins). This entry represents the catalytic domain found in a number of serine/threonine- and tyrosine-protein kinases. It does not include the catalytic domain of dual specificity kinases.


Pssm-ID: 462242 [Multi-domain]  Cd Length: 258  Bit Score: 52.88  E-value: 6.97e-08
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  80 VRQLKLVGEGAVKRVFLSEWNEH------KVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILT 148
Cdd:pfam07714   1 LTLGEKLGEGAFGEVYKGTLKGEgentkiKVAVKTLkegADEEEREDFLEEASIMKKLDHPNIVKLLGVCTQGEPlyIVT 80
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|
gi 1958684025 149 EYHPLGSLSNLeetlnLSKYRDVNTWQHRLRLAV------EYVSIINYLH 192
Cdd:pfam07714  81 EYMPGGDLLDF-----LRKHKRKLTLKDLLSMALqiakgmEYLESKNFVH 125
TyrKc smart00219
Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.
83-192 1.84e-07

Tyrosine kinase, catalytic domain; Phosphotransferases. Tyrosine-specific kinase subfamily.


Pssm-ID: 197581 [Multi-domain]  Cd Length: 257  Bit Score: 51.76  E-value: 1.84e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025   83 LKLVGEGAVKRVFLSEWNEH------KVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYH 151
Cdd:smart00219   4 GKKLGEGAFGEVYKGKLKGKggkkkvEVAVKTLkedASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEplYIVMEYM 83
                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....*..
gi 1958684025  152 PLGSLSNLeetlnLSKYRDVNTWQHRLRLAV------EYVSIINYLH 192
Cdd:smart00219  84 EGGDLLSY-----LRKNRPKLSLSDLLSFALqiargmEYLESKNFIH 125
STYKc smart00221
Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class ...
83-192 6.28e-07

Protein kinase; unclassified specificity; Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.


Pssm-ID: 214568 [Multi-domain]  Cd Length: 258  Bit Score: 49.85  E-value: 6.28e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025   83 LKLVGEGAVKRVFLSEWNEHK------VALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDG--TILTEYH 151
Cdd:smart00221   4 GKKLGEGAFGEVYKGTLKGKGdgkeveVAVKTLkedASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEplMIVMEYM 83
                           90       100       110       120
                   ....*....|....*....|....*....|....*....|....*...
gi 1958684025  152 PLGSLSNLeetlnLSKYRDVN-TWQHRLRLAV------EYVSIINYLH 192
Cdd:smart00221  84 PGGDLLDY-----LRKNRPKElSLSDLLSFALqiargmEYLESKNFIH 126
STKc_IRAK4 cd14158
Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; ...
85-192 1.04e-06

Catalytic domain of the Serine/Threonine kinase, Interleukin-1 Receptor Associated Kinase 4; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. IRAKs are involved in Toll-like receptor (TLR) and interleukin-1 (IL-1) signalling pathways, and are thus critical in regulating innate immune responses and inflammation. IRAKs contain an N-terminal Death domain (DD), a proST region (rich in serines, prolines, and threonines), a central kinase domain, and a C-terminal domain; IRAK-4 lacks the C-terminal domain. Vertebrates contain four IRAKs (IRAK-1, -2, -3 (or -M), and -4) that display distinct functions and patterns of expression and subcellular distribution, and can differentially mediate TLR signaling. IRAK4 plays a critical role in NFkB activation by its interaction with MyD88, which acts as a scaffold that enables IRAK4 to phosphorylate and activate IRAK1 and/or IRAK2. It also plays an important role in type I IFN production induced by TLR7/8/9. The IRAK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271060 [Multi-domain]  Cd Length: 288  Bit Score: 49.42  E-value: 1.04e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  85 LVGEGAVKRVFLSEWNEHKVALSRLTRL------EMKEDFLHGLRMLTSLQSQHVVTLAGF-CEEDGTILT-EYHPLGSL 156
Cdd:cd14158    22 KLGEGGFGVVFKGYINDKNVAVKKLAAMvdisteDLTKQFEQEIQVMAKCQHENLVELLGYsCDGPQLCLVyTYMPNGSL 101
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|
gi 1958684025 157 ----SNLEETLNLSkyrdvntWQHRLRLAVEYVSIINYLH 192
Cdd:cd14158   102 ldrlACLNDTPPLS-------WHMRCKIAQGTANGINYLH 134
PTKc cd00192
Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the ...
84-192 1.47e-06

Catalytic domain of Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers.The PTK family is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270623 [Multi-domain]  Cd Length: 262  Bit Score: 49.07  E-value: 1.47e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  84 KLVGEGAVKRVFLSEW-----NEHKVA---LSRLTRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPL 153
Cdd:cd00192     1 KKLGEGAFGEVYKGKLkggdgKTVDVAvktLKEDASESERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPlyLVMEYMEG 80
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|....*...
gi 1958684025 154 GSLSN-LEETLNLSKYRDVN--TWQHRLRLAV------EYVSIINYLH 192
Cdd:cd00192    81 GDLLDfLRKSRPVFPSPEPStlSLKDLLSFAIqiakgmEYLASKKFVH 128
STKc_RIP cd13978
Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze ...
87-319 2.16e-05

Catalytic domain of the Serine/Threonine kinase, Receptor Interacting Protein; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. RIP kinases serve as essential sensors of cellular stress. They are involved in regulating NF-kappaB and MAPK signaling, and are implicated in mediating cellular processes such as apoptosis, necroptosis, differentiation, and survival. RIP kinases contain a homologous N-terminal kinase domain and varying C-terminal domains. Higher vertebrates contain multiple RIP kinases, with mammals harboring at least five members. RIP1 and RIP2 harbor C-terminal domains from the Death domain (DD) superfamily while RIP4 contains ankyrin (ANK) repeats. RIP3 contain a RIP homotypic interaction motif (RHIM) that facilitates binding to RIP1. RIP1 and RIP3 are important in apoptosis and necroptosis, while RIP2 and RIP4 play roles in keratinocyte differentiation and inflammatory immune responses. The RIP subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270880 [Multi-domain]  Cd Length: 263  Bit Score: 45.52  E-value: 2.16e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  87 GEGAVKRVFLSEWNEH---KVALSRLTRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLGSLSNLEE 161
Cdd:cd13978     5 GFGTVSKARHVSWFGMvaiKCLHSSPNCIEERKALLKEAEKMERARHSYVLPLLGVCVERRSlgLVMEYMENGSLKSLLE 84
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 162 tlnlSKYRDVnTWQHRLRLAVEYVSIINYLHHSPlgtrvmcdsndlPKTLSQYLLTSNFsIVANDLDaLPLVDHGsrvLV 241
Cdd:cd13978    85 ----REIQDV-PWSLRFRIIHEIALGMNFLHNMD------------PPLLHHDLKPENI-LLDNHFH-VKISDFG---LS 142
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 242 KCGH-----------RELHGD--FVAPEQLWPYGEDTPFQDDLmppYDEKIDIWKI-------PDVSSFLLGHVEGSDMV 301
Cdd:cd13978   143 KLGMksisanrrrgtENLGGTpiYMAPEAFDDFNKKPTSKSDV---YSFAIVIWAVltrkepfENAINPLLIMQIVSKGD 219
                         250
                  ....*....|....*...
gi 1958684025 302 RFHLFDIHKACKNQFPAE 319
Cdd:cd13978   220 RPSLDDIGRLKQIENVQE 237
PTKc_Csk_like cd05039
Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases; PTKs catalyze the ...
79-207 7.55e-05

Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. This subfamily is composed of Csk, Chk, and similar proteins. They are cytoplasmic (or nonreceptor) PTKs containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. The Csk-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270635 [Multi-domain]  Cd Length: 256  Bit Score: 43.49  E-value: 7.55e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  79 EVRQLKLVGEGAVKRVFLSEWNEHKVALSRLTR-LEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLGS 155
Cdd:cd05039     7 DLKLGELIGKGEFGDVMLGDYRGQKVAVKCLKDdSTAAQAFLAEASVMTTLRHPNLVQLLGVVLEGNGlyIVTEYMAKGS 86
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|....*..
gi 1958684025 156 LSNLEEtlnlSKYRDVNTWQHRLRLAVEYVSIINYLH-----HSPLGTRVMCDSNDL 207
Cdd:cd05039    87 LVDYLR----SRGRAVITRKDQLGFALDVCEGMEYLEskkfvHRDLAARNVLVSEDN 139
STK_BAK1_like cd14664
Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; ...
86-196 9.76e-05

Catalytic domain of the Serine/Threonine Kinase, BRI1 associated kinase 1 and related STKs; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily includes three leucine-rich repeat receptor-like kinases (LRR-RLKs): Arabidopsis thaliana BAK1 and CLAVATA1 (CLV1), and Physcomitrella patens CLL1B clavata1-like receptor S/T protein kinase. BAK1 functions in various signaling pathways. It plays a role in BR (brassinosteroid)-regulated plant development as a co-receptor of BRASSINOSTEROID (BR) INSENSITIVE 1 (BRI1), the receptor for BRs, and is required for full activation of BR signaling. It also modulates pathways involved in plant resistance to pathogen infection (pattern-triggered immunity, PTI) and herbivore attack (wound- or herbivore feeding-induced accumulation of jasmonic acid (JA) and JA-isoleucine. CLV1, directly binds small signaling peptides, CLAVATA3 (CLV3) and CLAVATA3/EMBRYO SURROUNDING REGI0N (CLE), to restrict stem cell proliferation: the CLV3-CLV1-WUS (WUSCHEL) module influences stem cell maintenance in the shoot apical meristem, and the CLE40 (CLAVATA3/EMBRYO SURROUNDING REGION40) -ACR4 (CRINKLY4) -CLV1- WOX5 (WUSCHEL-RELATED HOMEOBOX5) module at the root apical meristem. The STK_BAK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271134 [Multi-domain]  Cd Length: 270  Bit Score: 43.25  E-value: 9.76e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  86 VGEGAVKRVFLSEWNEHK-VALSRLTRlEMKEDFLHG----LRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLGSLSN 158
Cdd:cd14664     1 IGRGGAGTVYKGVMPNGTlVAVKRLKG-EGTQGGDHGfqaeIQTLGMIRHRNIVRLRGYCSNPTTnlLVYEYMPNGSLGE 79
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|.
gi 1958684025 159 LeetLNLSKYRDVN-TWQHRLRLAVEYVSIINYLHH--SPL 196
Cdd:cd14664    80 L---LHSRPESQPPlDWETRQRIALGSARGLAYLHHdcSPL 117
PTKc_Jak_rpt2 cd05038
Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases; The Jak subfamily ...
79-231 1.07e-04

Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases; The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. They are PTKs, catalyzing the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jaks are cytoplasmic (or nonreceptor) PTKs containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. The Jak subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270634 [Multi-domain]  Cd Length: 284  Bit Score: 43.52  E-value: 1.07e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  79 EVRQLKLV---GEGAVKRVFLSEWNE------HKVALSRLTRlEMKE----DFLHGLRMLTSLQSQHVVTLAGFCEEDGT 145
Cdd:cd05038     2 EERHLKFIkqlGEGHFGSVELCRYDPlgdntgEQVAVKSLQP-SGEEqhmsDFKREIEILRTLDHEYIVKYKGVCESPGR 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 146 ----ILTEYHPLGSLSNLeetlnLSKYRDVNTWQHRLRLAVEYVSIINYLH-----HSPLGTR-VMCDSNDLPKT----L 211
Cdd:cd05038    81 rslrLIMEYLPSGSLRDY-----LQRHRDQIDLKRLLLFASQICKGMEYLGsqryiHRDLAARnILVESEDLVKIsdfgL 155
                         170       180
                  ....*....|....*....|
gi 1958684025 212 SQYLLTSNFSIVANDLDALP 231
Cdd:cd05038   156 AKVLPEDKEYYYVKEPGESP 175
PTKc_Tec_like cd05059
Catalytic domain of Tec-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the ...
79-158 2.47e-04

Catalytic domain of Tec-like Protein Tyrosine Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Tec-like subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. They are cytoplasmic (or nonreceptor) PTKs with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members except Rlk also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nonreceptor PTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. Tec kinases play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). The Tec-like subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 173637 [Multi-domain]  Cd Length: 256  Bit Score: 42.05  E-value: 2.47e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  79 EVRQLKLVGEGAVKRVFLSEW-NEHKVALSRLTRLEMKE-DFLHGLRMLTSLQSQHVVTLAGFCEEDGT--ILTEYHPLG 154
Cdd:cd05059     5 ELTFLKELGSGQFGVVHLGKWrGKIDVAIKMIKEGSMSEdDFIEEAKVMMKLSHPKLVQLYGVCTKQRPifIVTEYMANG 84

                  ....
gi 1958684025 155 SLSN 158
Cdd:cd05059    85 CLLN 88
PTKc_Trk cd05049
Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases; PTKs catalyze ...
86-159 2.63e-04

Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. They are receptor PTKs (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. The Trk subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270643 [Multi-domain]  Cd Length: 280  Bit Score: 42.07  E-value: 2.63e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  86 VGEGAVKRVFLSEW-------NEHKVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGTILT--EYHPL 153
Cdd:cd05049    13 LGEGAFGKVFLGECynlepeqDKMLVAVKTLkdaSSPDARKDFEREAELLTNLQHENIVKFYGVCTEGDPLLMvfEYMEH 92

                  ....*.
gi 1958684025 154 GSLSNL 159
Cdd:cd05049    93 GDLNKF 98
STKc_MLTK cd14060
Catalytic domain of the Serine/Threonine Kinase, Mixed lineage kinase-Like mitogen-activated ...
87-256 6.00e-04

Catalytic domain of the Serine/Threonine Kinase, Mixed lineage kinase-Like mitogen-activated protein Triple Kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. MLTK, also called zipper sterile-alpha-motif kinase (ZAK), contains a catalytic kinase domain and a leucine zipper. There are two alternatively-spliced variants, MLTK-alpha and MLTK-beta. MLTK-alpha contains a sterile-alpha-motif (SAM) at the C-terminus. MLTK regulates the c-Jun N-terminal kinase, extracellular signal-regulated kinase, p38 MAPK, and NF-kB pathways. ZAK is the MAP3K involved in the signaling cascade that leads to the ribotoxic stress response initiated by cellular damage due to Shiga toxins and ricin. It may also play a role in cell transformation and cancer development. MAP3Ks (MKKKs or MAPKKKs) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.The MLTK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270962 [Multi-domain]  Cd Length: 242  Bit Score: 40.71  E-value: 6.00e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  87 GEGAVKRVFLSEW--NEHKVALSRLTRLEMKEDflhglrMLTSLQSQHVVTLAGFCEE--DGTILTEYHPLGSL-----S 157
Cdd:cd14060     2 GGGSFGSVYRAIWvsQDKEVAVKKLLKIEKEAE------ILSVLSHRNIIQFYGAILEapNYGIVTEYASYGSLfdylnS 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 158 NLEETLNLSKyrdVNTWqhrlrlAVEYVSIINYLH-HSPLgtrvmcdsndlpKTLSQYLLTSNFSIVANDLdaLPLVDHG 236
Cdd:cd14060    76 NESEEMDMDQ---IMTW------ATDIAKGMHYLHmEAPV------------KVIHRDLKSRNVVIAADGV--LKICDFG 132
                         170       180
                  ....*....|....*....|...
gi 1958684025 237 -SRVLVKCGHRELHGDF--VAPE 256
Cdd:cd14060   133 aSRFHSHTTHMSLVGTFpwMAPE 155
PTKc_EGFR cd05108
Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor; PTKs ...
78-262 9.20e-04

Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a receptor PTK (RTK) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other PTKs, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. The EGFR subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270683 [Multi-domain]  Cd Length: 313  Bit Score: 40.78  E-value: 9.20e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  78 TEVRQLKLVGEGAVKRVFLSEWNEH------KVALSRL---TRLEMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGT-IL 147
Cdd:cd05108     7 TEFKKIKVLGSGAFGTVYKGLWIPEgekvkiPVAIKELreaTSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVqLI 86
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 148 TEYHPLGSLSNLeetlnLSKYRDVNTWQHRLRLAVEYVSIINYLHHSPLGTRVMCDSNDLPKTlSQYLLTSNFSIvANDL 227
Cdd:cd05108    87 TQLMPFGCLLDY-----VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGL-AKLL 159
                         170       180       190
                  ....*....|....*....|....*....|....*....
gi 1958684025 228 DALPLVDH--GSRVLVKCGHRE--LHGDFVAPEQLWPYG 262
Cdd:cd05108   160 GAEEKEYHaeGGKVPIKWMALEsiLHRIYTHQSDVWSYG 198
PTKc_Csk cd05082
Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase; PTKs catalyze the ...
77-333 1.85e-03

Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase; PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Csk is a cytoplasmic (or nonreceptor) PTK containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. The Csk subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 133213 [Multi-domain]  Cd Length: 256  Bit Score: 39.58  E-value: 1.85e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  77 RTEVRQLKLVGEGAVKRVFLSEWNEHKVALSRLTRLEMKEDFLHGLRMLTSLQSQHVVTLAG-FCEEDGT--ILTEYHPL 153
Cdd:cd05082     5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGvIVEEKGGlyIVTEYMAK 84
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 154 GSLSNLEEtlnlSKYRDVNTWQHRLRL------AVEYVSIINYLHHSPLGTRVMCDSNDLPKtLSQYLLTSNFSIVaNDL 227
Cdd:cd05082    85 GSLVDYLR----SRGRSVLGGDCLLKFsldvceAMEYLEGNNFVHRDLAARNVLVSEDNVAK-VSDFGLTKEASST-QDT 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 228 DALPLVDHGSRVLvkcghRElhGDFVAPEQLWPYG----EDTPFQDDLMP--PYDEkidiwKIPDVSS-FLLGHVEGSDM 300
Cdd:cd05082   159 GKLPVKWTAPEAL-----RE--KKFSTKSDVWSFGillwEIYSFGRVPYPriPLKD-----VVPRVEKgYKMDAPDGCPP 226
                         250       260       270
                  ....*....|....*....|....*....|...
gi 1958684025 301 VrfhLFDIHKACKNQFPAERPTAQNVLDAYQKV 333
Cdd:cd05082   227 A---VYDVMKNCWHLDAAMRPSFLQLREQLEHI 256
STKc_LIMK cd14154
Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer ...
113-296 6.13e-03

Catalytic domain of the Serine/Threonine Kinase, LIM domain kinase; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. LIMKs phosphorylate and inactivate cofilin, an actin depolymerizing factor, to induce the reorganization of the actin cytoskeleton. They act downstream of Rho GTPases and are expressed ubiquitously. As regulators of actin dynamics, they contribute to diverse cellular functions such as cell motility, morphogenesis, differentiation, apoptosis, meiosis, mitosis, and neurite extension. LIMKs contain the LIM (two repeats), PDZ, and catalytic kinase domains. Vertebrate have two members, LIMK1 and LIMK2. The LIMK subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 271056 [Multi-domain]  Cd Length: 272  Bit Score: 37.87  E-value: 6.13e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 113 EMKEDFLHGLRMLTSLQSQHVVTLAGFCEEDGTI--LTEYHPLGSLSNLeetlnLSKYRDVNTWQHRLRLAVEYVSIINY 190
Cdd:cd14154    32 EAQRNFLKEVKVMRSLDHPNVLKFIGVLYKDKKLnlITEYIPGGTLKDV-----LKDMARPLPWAQRVRFAKDIASGMAY 106
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025 191 LHHSPLGTRVMCDSNDLPKtLSQYLLTSNF----SIVANDLDA-LPLVDHGSRVLVKCGHRELH---GD--FVAPEQLwp 260
Cdd:cd14154   107 LHSMNIIHRDLNSHNCLVR-EDKTVVVADFglarLIVEERLPSgNMSPSETLRHLKSPDRKKRYtvvGNpyWMAPEML-- 183
                         170       180       190
                  ....*....|....*....|....*....|....*.
gi 1958684025 261 YGEDtpfqddlmppYDEKIDIWKIPDVSSFLLGHVE 296
Cdd:cd14154   184 NGRS----------YDEKVDIFSFGIVLCEIIGRVE 209
STKc_TGFbR_I cd14056
Catalytic domain of the Serine/Threonine Kinases, Transforming Growth Factor beta family Type ...
84-199 8.04e-03

Catalytic domain of the Serine/Threonine Kinases, Transforming Growth Factor beta family Type I Receptors; STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This subfamily is composed of type I receptors for the TGFbeta family of secreted signaling molecules including TGFbeta, bone morphogenetic proteins, activins, growth and differentiation factors, and anti-Mullerian hormone, among others. These receptors contain an extracellular domain that binds ligands, a single transmembrane (TM) region, and a cytoplasmic catalytic kinase domain. Type I receptors are low-affinity receptors that bind ligands only after they are recruited by the ligand/type II high-affinity receptor complex. Following activation through trans-phosphorylation by type II receptors, they start intracellular signaling to the nucleus by phosphorylating SMAD proteins. Type I receptors contain an additional domain located between the TM and kinase domains called the GS domain, which contains the activating phosphorylation site and confers preference for specific SMAD proteins. They are inhibited by the immunophilin FKBP12, which is thought to control leaky signaling caused by receptor oligomerization in the absence of ligand. The TGFbR-I subfamily is part of a larger superfamily that includes the catalytic domains of other STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase.


Pssm-ID: 270958 [Multi-domain]  Cd Length: 287  Bit Score: 37.64  E-value: 8.04e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1958684025  84 KLVGEGAVKRVFLSEWNEHKVALSRLTRLEM----KEDFLHGLRMLtslqsQHVVTLaGFCEEDGT---------ILTEY 150
Cdd:cd14056     1 KTIGKGRYGEVWLGKYRGEKVAVKIFSSRDEdswfRETEIYQTVML-----RHENIL-GFIAADIKstgswtqlwLITEY 74
                          90       100       110       120       130
                  ....*....|....*....|....*....|....*....|....*....|.
gi 1958684025 151 HPLGSLSN--LEETLNLSKYrdvntwqhrLRLAVEYVSIINYLHHSPLGTR 199
Cdd:cd14056    75 HEHGSLYDylQRNTLDTEEA---------LRLAYSAASGLAHLHTEIVGTQ 116
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH